C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 233/40 (2006.01) C07C 235/34 (2006.01) C07D 207/32 (2006.01) C07D 209/20 (2006.01) C07D 213/40 (2006.01) C07D 215/42 (2006.01) C07D 233/54 (2006.01) C07D 311/68 (2006.01) C07D 335/06 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2573138
The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a colletion of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
L'invention concerne de nouveaux composés et procédés pour traiter des maladies, des troubles, et des états associés à l'amylose. L'amylose désigne un ensemble de maladies, de troubles et d'états associés à un dépôt anormal de protéine A-bêta.
Aquino Jose
Jagodzinska Barbara
John Varghese
Maillard Michel
Probst Gary
Elan Pharmaceuticals Inc.
Kirby Eades Gale Baker
LandOfFree
Oxime derivative substituted hydroxyethylamine aspartyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxime derivative substituted hydroxyethylamine aspartyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxime derivative substituted hydroxyethylamine aspartyl... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1930249